Biodexa Pharmaceuticals (BDRX) Asset Management (2014 - 2017)
Biodexa Pharmaceuticals (BDRX) posted Asset Management of $132766.5 for Q4 2017, up 48.32% sequentially from $89512.0 in Q4 2016, and up 48.32% YoY from $89512.0 in Q4 2016.
Biodexa Pharmaceuticals (BDRX) Asset Management (2014 - 2017) Analysis & Trends
Biodexa Pharmaceuticals has reported Asset Management for 4 years, with the latest figure at $132766.5 in Q4 2017.
- Quarterly Asset Management rose 48.32% year-over-year to $132766.5 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $286414.6 (changed N/A YoY) and the FY2017 annual result came in at $128823.5, down 98.51% from the prior year.
- Asset Management improved to $132766.5 in Q4 2017 per BDRX's latest filing, from $89512.0 in the prior quarter.
- Over five years, Asset Management peaked at $132766.5 in Q4 2017 and troughed at $9506.4 in Q4 2014.
- A 4-year average of $71603.6 and a median of $72070.8 in 2015 frame the typical range for Asset Management.
- The sharpest annual moves came in 2015 and 2017: Asset Management surged 474.66% in 2015, then jumped 48.32% in 2017.
- Over 4 years, Asset Management stood at $9506.4 in 2014, then soared by 474.66% to $54629.7 in 2015, then jumped by 63.85% to $89512.0 in 2016, then jumped by 48.32% to $132766.5 in 2017.
- According to Business Quant data, Asset Management over the past three periods registered $132766.5, $89512.0, and $54629.7 for Q4 2017, Q4 2016, and Q4 2015 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Biodexa Pharmaceuticals | 63,168.17 | -11.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 132,766.48 |
| Dec 31, 2016 | 89,512.00 |
| Dec 31, 2015 | 54,629.66 |
| Dec 31, 2014 | 9,506.42 |